Journal article

Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.

NS Majhail, JD Rizzo, SJ Lee, M Aljurf, Y Atsuta, C Bonfim, LJ Burns, N Chaudhri, S Davies, S Okamoto, A Seber, G Socie, J Szer, MT Van Lint, JR Wingard, A Tichelli, undefined Center for International Blood and Marrow Transplant Research (CIBMTR), undefined American Society for Blood and Marrow Transplantation (ASBMT), undefined European Group for Blood and Marrow Transplantation (EBMT), undefined Asia-Pacific Blood and Marrow Transplantation Group (APBMT) Show all

Hematology/Oncology and Stem Cell Therapy | Published : 2012


Advances in hematopoietic cell transplantation (HCT) technology and supportive care techniques have led to improvements in long-term survival after HCT. Emerging indications for transplantation, introduction of newer graft sources (eg, umbilical cord blood) and transplantation of older patients using less intense conditioning regimens have also contributed to an increase in the number of HCT survivors. These survivors are at risk for developing late complications secondary to pre-, peri-, and posttransplant exposures and risk factors. Guidelines for screening and preventive practices for HCT survivors were published in 2006. An international group of transplantation experts was convened in 2..

View full abstract